BridgeBio Oncology Therapeutics, Inc.
BBOT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869105
No open-market purchases or sales by BridgeBio Oncology Therapeutics, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $450.6M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in BridgeBio Oncology Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +9 vs. Q2 2025
- Shares held
- 56.8M
- +40.3M (+244.1%) vs. Q2 2025
- Total value
- $657.5M
- +$482.1M (+274.8%) vs. Q2 2025
- New holders
- 24
- 10 more added
- Sold out
- 15
- 7 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BBOT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 65 | $450.6M |
| Q1 2026 | 67 | $513.8M |
| Q4 2025 | 52 | $724.7M |
| Q3 2025 | 42 | $657.5M |
| Q2 2025 | 34 | $177.6M |
| Q1 2025 | 31 | $186.3M |
| Q4 2024 | 32 | $172.7M |
| Q3 2024 | 31 | $171.1M |
| Q2 2024 | 31 | $167.4M |
| Q1 2024 | 29 | $166.9M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding BridgeBio Oncology Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 16 | $0 | 0.00% | +16 | New |
| FNY Investment Advisers, LLC | 100 | $1.00K | 0.00% | −27,084−99.6% | Reduced |
| Morgan Stanley | 861 | $9.97K | 0.00% | +861 | New |
| Bank of America Corp | 1,329 | $15.4K | 0.00% | +1,329 | New |
| China Universal Asset Management Co., Ltd. | 5,000 | $57.9K | 0.00% | +5,000 | New |
| XTX Topco Ltd | 23,384 | $270.8K | 0.01% | +23,384 | New |
| UBS Group AG | 52,226 | $604.8K | 0.00% | −16,308−23.8% | Reduced |
| Northern Trust Corp | 95,957 | $1.11M | 0.00% | +95,957 | New |
| Boothbay Fund Management, LLC | 96,551 | $1.12M | 0.03% | +96,551 | New |
| Moore Capital Management, LP | 100,000 | $1.16M | 0.02% | 00.0% | Unchanged |
| Woodline Partners LP | 103,707 | $1.20M | 0.01% | +460+0.4% | Added |
| TD Asset Management Inc | 130,062 | $1.51M | 0.00% | −14,710−10.2% | Reduced |
| Sio Capital Management, LLC | 130,628 | $1.51M | 0.38% | +130,628 | New |
| FMR LLC | 162,077 | $1.88M | 0.00% | +162,077 | New |
| State Street Corp | 176,695 | $2.05M | 0.00% | +176,695 | New |
| StemPoint Capital LP | 186,614 | $2.16M | 0.44% | −129,198−40.9% | Reduced |
| Ikarian Capital, LLC | 245,231 | $2.84M | 0.64% | +245,231 | New |
| Charles Schwab Investment Management Inc | 279,350 | $3.23M | 0.00% | +279,350 | New |
| Casdin Capital, LLC | 282,312 | $3.27M | 0.27% | +282,312 | New |
| Millennium Management LLC | 369,563 | $4.06M | 0.00% | −527,688−58.8% | Reduced |
| Armistice Capital, LLC | 412,000 | $4.77M | 0.15% | +412,000 | New |
| Silverarc Capital Management, LLC | 457,414 | $5.30M | 0.77% | −155,979−25.4% | Reduced |
| ADAR1 Capital Management, LLC | 501,228 | $5.80M | 0.57% | +58,613+13.2% | Added |
| Geode Capital Management, LLC | 541,602 | $6.27M | 0.00% | +528,274+3,963.6% | Added |
| Aisling Capital Management LP | 564,625 | $6.54M | 1.43% | +564,625 | New |
| Vanguard Group Inc | 647,599 | $7.50M | 0.00% | +647,599 | New |
| Price T Rowe Associates Inc | 885,042 | $10.2M | 0.00% | −186,508−17.4% | Reduced |
| Octagon Capital Advisors LP | 1,043,110 | $12.1M | 1.89% | +793,110+317.2% | Added |
| Laurion Capital Management LP | 1,045,800 | $12.1M | 1.65% | +745,800+248.6% | Added |
| Eventide Asset Management, LLC | 1,082,362 | $12.4M | 0.20% | +1,082,362 | New |
| Adage Capital Partners GP, L.L.C. | 1,487,621 | $17.2M | 0.03% | +87,621+6.3% | Added |
| Paradigm Biocapital Advisors LP | 1,866,141 | $21.6M | 0.64% | +1,866,141 | New |
| Novo Holdings A/S | 1,961,317 | $22.7M | 1.46% | +1,961,317 | New |
| BlackRock, Inc. | 2,048,552 | $23.7M | 0.00% | +549,687+36.7% | Added |
| Citadel Advisors LLC | 2,538,141 | $29.4M | 0.02% | +1,110,940+77.8% | Added |
| Enavate Sciences GP, LLC | 2,626,946 | $30.4M | 9.29% | +2,626,946 | New |
| EcoR1 Capital, LLC | 2,823,126 | $32.7M | 1.57% | +2,823,126 | New |
| Alphabet Inc. | 2,823,126 | $32.7M | 1.36% | +2,823,126 | New |
| Wellington Management Group LLP | 2,961,263 | $34.3M | 0.01% | +2,776,673+1,504.2% | Added |
| Omega Fund Management, LLC | 3,289,661 | $38.1M | 17.13% | +3,289,661 | New |
| Deerfield Management Company, L.P. (Series C) | 4,885,446 | $56.6M | 0.87% | +4,885,446 | New |
| Cormorant Asset Management, LP | 17,878,594 | $207.0M | 14.29% | +14,969,594+514.6% | Added |
| Sculptor Capital LP | 0 | $0 | 0.00% | −800,000−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −600,000−100.0% | Sold out |
| Harraden Circle Investments, LLC | 0 | $0 | 0.00% | −569,831−100.0% | Sold out |
| Berkley W R Corp | 0 | $0 | 0.00% | −445,195−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −444,377−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −398,000−100.0% | Sold out |
| Decagon Asset Management LLP | 0 | $0 | 0.00% | −348,223−100.0% | Sold out |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −292,338−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −210,125−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −187,257−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −108,300−100.0% | Sold out |
| K2 Principal Fund, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −29,381−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |